Authors
Latest:
Will Resistance Associated Variants Affect the HCV Treatment Paradigm?Specialty pharmacists play an important role in making evidence-based recommendations for the treatment of hepatitis C virus.
Latest:
Making It Through ASHP Midyear: Advice from FellowsThe ASHP Midyear Clinical Meeting and Exhibition gives pharmacy students the chance to learn more about postdoctoral training programs, including fellowship and residency opportunities.
Latest:
Intravenous Lidocaine Can Treat Acute PainAnalgesic Alternatives May Help Reduce Unnecessary Exposure to Opioid Medications
Latest:
Improving Outcomes for Patients With Breast CancerCurrent cancer research focuses heavily on adjunct immunotherapy in combination with traditional chemotherapy.
Latest:
Duration of Antibiotic Therapy: General PrinciplesDeciding on the duration of antimicrobial therapy for an infection is neither straightforward nor simple.
Latest:
Health Systems Should Better Integrate Pharmacy ArrangementsIdeally, these contracts help address criticism of the 340B program, improve patient outcomes, and increase compliance.
Latest:
Together Beyond COVID-19: A Look at the Future of the Pharmaceutical IndustryIn a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.
Latest:
PharmD Students Cope With Transitions in the Wake of the COVID-19 PandemicThe COVID-19 pandemic rapidly pushed traditional face-to-face instruction within schools of pharmacy into a fully remote learning environment.
Latest:
Choose the Most Appropriate Therapy to Fight InfluenzaBaloxavir marboxil and oseltamivir are options for treating uncomplicated influenza.
Latest:
Cannabidiol Presents ConundrumsRecent federal legalization and increases sales of CBD underscore the importance of considering its pharmacologic impact.
Latest:
Toxicity Is a Risk of PAMORA InteractionsPeripherally acting M-opioid receptor antagonists can improve quality of life but differ variably by impact from concomitant medications.
Latest:
Which Left Ventricular Assist Device Is Best?Advanced heart failure leads to significant limitations, affecting functional status, quality of life, and survival, despite optimal medical treatment with evidence-based therapies.
Latest:
10 Strategies for Minimizing Dispensing ErrorsDispensing errors can be costly for the pharmacist as well as potentially dangerous for the patient. Pharmacists can take simple steps to help eliminate this problem.
Latest:
A Collaborative Approach to Specialty Pharmacy at an Academic Medical CenterThe SUNY Outpatient Pharmacy has developed a strong collaboration with specialty pharmacy personnel and clinically embedded pharmacists.
Latest:
Healthcare Utilization and Costs for Insured Patients With FibromyalgiaFibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.
Latest:
The Benefit of Dual Degree ProgramsAs a student pharmacist, it can be difficult to keep up with the fast-paced changes of the pharmacy profession. As the pharmacy profession continues to expand, we must continue to challenge ourselves by advancing our education and training.
Latest:
The Pharmaceutical Ecosystem Must Work Together to Provide Sustainable Innovation and Ensure Patient AccessGrowth in the use of specialty drugs demands the evolution of patient care models that leverage the knowledge of all relevant stakeholders.Â
Latest:
End of OCM Brings Drop-Off in Value-Based Care Volume, New QuestionsQuestions arise around equity and revenue challenges.
Latest:
Outcomes of a Specialty Pharmacy Program for Oral Oncology MedicationsOur research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
340B Drug Discount Program in the Cross HairsThe drug industry wants to shrink the 340B drug discount program; however, safety net providers insist it is vital to treating the poor.
Latest:
The Community Pharmacist Role in Antiemetic Therapy for Outpatient Chemotherapy TreatmentDespite improvements in the understanding and treatment of chemotherapy-induced nausea and vomiting (CINV), nausea and emesis continue to be a distressing adverse event for patients.
